FDA To Consider Approval Of New Emergency Contraceptive Ulipristal Acetate

An FDA advisory committee is scheduled to meet June 17 to consider approval of the emergency contraception ulipristal acetate, which studies show is more effective than a currently approved EC — levonorgestrel — at preventing , USA Today reports. Levonorgestrel, marketed in the U.S…


Read more

Related posts

Leave a Reply